Cytokinetics, Incorporated (CYTK)

Cytokinetics Revenue

Cytokinetics had revenue of $19.36M in the quarter ending March 31, 2026, with 1,125.78% growth. This brings the company's revenue in the last twelve months to $105.82M, up 450.60% year-over-year. In the year 2025, Cytokinetics had annual revenue of $88.04M with 376.56% growth.

• Revenue (ttm): $105.82M
• Revenue Growth: +450.60%
• P/S Ratio: 90.01
• Revenue / Employee: $157,229
• Employees: 673
• Market Cap: 9.52B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	88.04M	69.57M	376.56%
Dec 31, 2024	18.47M	10.94M	145.34%
Dec 31, 2023	7.53M	-87.06M	-92.04%
Dec 31, 2022	94.59M	24.16M	34.30%
Dec 31, 2021	70.43M	14.60M	26.15%
Dec 31, 2020	55.83M	28.96M	107.79%
Dec 31, 2019	26.87M	-4.63M	-14.71%
Dec 31, 2018	31.50M	18.13M	135.64%
Dec 31, 2017	13.37M	-93.04M	-87.44%
Dec 31, 2016	106.41M	77.75M	271.30%
Dec 31, 2015	28.66M	-18.28M	-38.95%
Dec 31, 2014	46.94M	16.29M	53.16%
Dec 31, 2013	30.65M	23.09M	305.45%
Dec 31, 2012	7.56M	3.56M	88.98%
Dec 31, 2011	4.00M	1.42M	55.22%
Dec 31, 2010	2.58M	-78.96M	-96.84%
Dec 31, 2009	81.54M	69.12M	556.51%
Dec 31, 2008	12.42M	-1.20M	-8.82%
Dec 31, 2007	13.62M	10.50M	335.63%
Dec 31, 2006	3.13M	-5.79M	-64.91%
Dec 31, 2005	8.91M	-	-

Data Source: Fiscal.ai Last updated: May 5, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 11, 2026

Data Sources Report a data error